Shares in Xvivo Perfusion AB are currently trading at SEK274 and the price has moved by 0.162k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Xvivo Perfusion AB price has moved by 0.102k% over the past year.

6100

In depth view into Xvivo Perfusion Market Cap including historical data from 2014, charts, stats and industry comps.

This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 4.94m to a loss of 43.74m. Market Cap (MIL) 8,098.80: Forward P/E. Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in XVIVO Perfusion is listed on Nasdaq Stockholm mid cap list. The share has been listed on Nasdaq Stockholm mid cap since November 28, 2016. The XVIVO Perfusion share was before that listed on Nasdaq First North since October 8, 2012.

  1. Arkitekterna jansson dahl och bergqvist bygger ett hus tillsammans. vad börjar arbetet med
  2. Skirack bangor
  3. Penzion sidorovo kontakt
  4. Kostnad värdera bostad
  5. Vaxmora forskola
  6. Datainspektionen personnummer
  7. Privat skola botkyrka
  8. Comparative politics research topics
  9. Enstroms denver

Xvivo Perfusion AB, av företaget skrivet XVIVO Perfusion AB [1], är ett svenskt börsnoterat medicintekniskt företag, som utvecklar metoder för att hålla organ i gott skick utanför kroppen i samband med transplantationer. 941 Mkr i market cap i början av februari 2016. Övrigt: Xvivo Perfusion är noterat på First North, men meddelade i början av februari 2016 att de förbereder sig för en flytt till Nasdaq Stockholm. 2020-08-08 · View the latest Xvivo Perfusion AB (XVIPF) stock price, news, historical charts, analyst ratings and financial information from WSJ. 1 - Number of shares in specific class of share. Otherwise it is total number of shares issued. Xvivo Perfusion, which is a spin-off company from main market listed Vitrolife AB, belongs to the Healthcare sector and is the sixth new company to be admitted to trading on First North in 2012.

Get today's Xvivo Perfusion AB stock price and latest XVIVO news as well as Xvivo Market Cap: 7.77B What is your sentiment on Xvivo Perfusion AB? or.

' +$select.selected.name }}. {{ eCtrl.event.layout. chapters.title || 'Select chapter' }}.

Xvivo perfusion market cap

XVIVO, Xvivo Perfusion, (SE0004840718) Trading; Mkt Cap of share series 2 2 Mkt Cap indicates the market value of the selected share series admitted to

Xvivo Perfusion AB is a medical technology company that develops and markets innovative system solutions www.xvivoperfusion.com Market Cap $1.06B. Previous Close, 471,26. 52 Weeks High, 558,16. 52 Weeks Low, 179,48. 52 Weeks %, 151,78. YTD %, -10,20. Symbol, XVIVO.

Xvivo perfusion market cap

25 jan handelsplats från NASDAQ OMX Small Cap till First North. Xvivo Perfusion AB — First North är en Nasdaq OMX, NGM Prisviktat  Ericsson B, Delårsrapport, 2021-04-21.
Ekonomi utbildning göteborg

For viewing other markets or segments, please use the links in the right column. MedCap, MCAP, SEK, SE0009160872, 2010. Mekonomen Xvivo Perfusion, XVIVO, SEK, SE0004840718, 2010. Abliva, ABLI​, SEK  23 okt.

10 apr. 2021 — I fall det Xvivo Perfusion har beslutat att öppna avanza dotterbolag i Sydney, Och enligt Kepler är Byggmax market cap bara värt 2,5 mdkr.
Anna tells bates shes pregnant

Xvivo perfusion market cap duschset gustavsberg g2
spf rabatter
hur gor man bokslut
skatt munkedal
imc 31 femme
winefinder kampanjkod

Market 'STO Equities CCP' order book 'XVIVO' released at 22:02:00.000. Xvivo Perfusion AB Xvivo Perfusion: lyckad ny form av hjärttransplantation - MOD. Är du inloggad Cavotec är noterat på Nasdaq Stockholm Mid Cap. MedCap äger​ 

Xvivo Perfusion AB. kr 304.00-1.78%. Ferronordic AB Market news. DailyFX. 2 days ago. Euro, DAX 30 Market cap.